Nivolumab plus regorafenib in patients with small bowel adenocarcinoma: A case report

INTRODUCTION: Small bowel adenocarcinomas (SBAs) are rare cancers that have a distinct clinical characteristic and genetic profile. The only potentially curative treatment for localized SBAs is surgery, and treatment options are limited for patients in the advanced stage of disease. PATIENT CONCERNS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Gairong, Lin, Li, Dong, Dapeng, Qiu, Hui, Liu, Tao, Lian, Li, Shen, Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850762/
https://www.ncbi.nlm.nih.gov/pubmed/33530218
http://dx.doi.org/10.1097/MD.0000000000024295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850762/
https://www.ncbi.nlm.nih.gov/pubmed/33530218
http://dx.doi.org/10.1097/MD.0000000000024295

Ejemplares similares